SWOG clinical trial number
SWOG-8319
Evaluation of Fludarabine Phosphate in Ovarian Cancer
Closed
Phase
Published
Abbreviated Title
Evaluation of Fludarabine Phosphate in Ovarian Cancer
Activated
06/01/1984
Closed
06/30/1986
Publication Information Expand/Collapse
1988
Phase II study of fludarabine phosphate (NSC-312887) in patientswith advanced ovarian cancer. A Southwest Oncology Group study.